CJC1295 (no-DAC) 5mg + Ipamorelin 5mg/10mg
This product comprises two research-use-only peptides, CJC1295 (no-DAC) and Ipamorelin, in a combined formulation. These peptides are designed for scientific investigation purposes only.
Research Context
CJC1295 (no-DAC), also known as Tetranexin, is an analog of CJC 1037, which mimics the effects of growth hormone-releasing hormone (GHRH). It does not contain dacarbazine (DAC) and has a longer half-life than its parent compound. Ipamorelin, on the other hand, is another GHRH receptor agonist that has been extensively studied for its potential to stimulate growth hormone release.
Research Overview
The combination of CJC1295 (no-DAC) and Ipamorelin can be used in various research settings. Both peptides have shown promise in enhancing growth hormone levels, which may have implications in the study of aging, muscle health, and metabolic processes.
Key Research Focus Areas
- Growth Hormone Release: Studies often focus on how these peptides stimulate the pituitary gland to release growth hormone.
- Muscle Growth and Repair: These peptides are of particular interest in muscle physiology, as they can influence muscle protein synthesis and recovery.
- Aging Research: Given their ability to increase growth hormone levels, these peptides have been explored for their potential anti-aging effects through various mechanisms, including improved cellular function and metabolism.
For research use only. Not for human or animal consumption.